CIP
SGNT

Convergence Investment Partners’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Convergence Investment Partners’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-45,538
Closed -$1.11M – 454
2015
Q2 		$1.11M Sell
45,538
-15,002
-25% -$359K 0.11% 263
2015
Q1 		$1.41M Buy
60,540
+18,790
+45% +$497K 0.2% 204
2014
Q4 		$1.05M Buy
+41,750
New +$1.22M 0.14% 242

Other funds holding SGNT

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Convergence Investment Partners's SGNT Position: Q3 2015 in Review

Convergence Investment Partners sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2015, closing a stake of 45,538 shares — an estimated $1.11M sold.

Convergence Investment Partners first reported a position in SGNT in Q4 2014 and held it in 3 quarters. The position peaked at $1.41M in Q1 2015. 127 funds tracked by Wall St. Rank hold SGNT as of Q3 2015.

  • Convergence Investment Partners reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2015 after selling out during the quarter.
  • Convergence Investment Partners sold 45,538 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2015, an estimated $1.11M.
  • Convergence Investment Partners first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q4 2014 and held it in 3 quarters.
  • Convergence Investment Partners's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $1.41M in Q1 2015.
  • 127 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2015.

Based on Convergence Investment Partners's 13F filing for Q3 2015, filed 16 Nov 2015.